These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Trastuzumab-polyethylenimine-polyethylene glycol conjugates for targeting Her2-expressing tumors. Germershaus O; Merdan T; Bakowsky U; Behe M; Kissel T Bioconjug Chem; 2006; 17(5):1190-9. PubMed ID: 16984128 [TBL] [Abstract][Full Text] [Related]
9. Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate. Govindarajan S; Sivakumar J; Garimidi P; Rangaraj N; Kumar JM; Rao NM; Gopal V Biomaterials; 2012 Mar; 33(8):2570-82. PubMed ID: 22192536 [TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo. Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413 [TBL] [Abstract][Full Text] [Related]
11. Antibody-mediated gene delivery for B-cell lymphoma in vitro. Schachtschabel U; Pavlinkova G; Lou D; Köhler H Cancer Gene Ther; 1996; 3(6):365-72. PubMed ID: 8988839 [TBL] [Abstract][Full Text] [Related]
12. Antibody-mediated targeting of replication-competent retroviral vectors. Tai CK; Logg CR; Park JM; Anderson WF; Press MF; Kasahara N Hum Gene Ther; 2003 May; 14(8):789-802. PubMed ID: 12804141 [TBL] [Abstract][Full Text] [Related]
13. Gluconoylated and glycosylated polylysines as vectors for gene transfer into cystic fibrosis airway epithelial cells. Kollen WJ; Midoux P; Erbacher P; Yip A; Roche AC; Monsigny M; Glick MC; Scanlin TF Hum Gene Ther; 1996 Aug; 7(13):1577-86. PubMed ID: 8864758 [TBL] [Abstract][Full Text] [Related]
14. Specific tumoricidal activity of a secreted proapoptotic protein consisting of HER2 antibody and constitutively active caspase-3. Jia LT; Zhang LH; Yu CJ; Zhao J; Xu YM; Gui JH; Jin M; Ji ZL; Wen WH; Wang CJ; Chen SY; Yang AG Cancer Res; 2003 Jun; 63(12):3257-62. PubMed ID: 12810656 [TBL] [Abstract][Full Text] [Related]
15. Trastuzumab-targeted gene delivery to Her2-overexpressing breast cancer cells. Mann K; Kullberg M Cancer Gene Ther; 2016 Jul; 23(7):221-8. PubMed ID: 27199219 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of human lung cancer cell line growth by an anti-p185HER2 antibody. Kern JA; Torney L; Weiner D; Gazdar A; Shepard HM; Fendly B Am J Respir Cell Mol Biol; 1993 Oct; 9(4):448-54. PubMed ID: 8104437 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of the p27Kip1-mediated antiproliferative effect of trastuzumab (Herceptin) on HER2-overexpressing tumor cells. Marches R; Uhr JW Int J Cancer; 2004 Nov; 112(3):492-501. PubMed ID: 15382077 [TBL] [Abstract][Full Text] [Related]
18. Anti-Her2 single-chain antibody mediated DNMTs-siRNA delivery for targeted breast cancer therapy. Dou S; Yao YD; Yang XZ; Sun TM; Mao CQ; Song EW; Wang J J Control Release; 2012 Aug; 161(3):875-83. PubMed ID: 22762887 [TBL] [Abstract][Full Text] [Related]
19. Bispecific anti-HER2 and CD16 single-chain antibody production prolongs the use of stem cell-like cell transplantation against HER2-overexpressing cancer. Kasuya K; Shimazu M; Suzuki M; Itoi T; Aoki T; Tsuchida A Int J Mol Med; 2010 Feb; 25(2):209-15. PubMed ID: 20043129 [TBL] [Abstract][Full Text] [Related]
20. Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-gamma-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector. Huang H; Yu H; Tang G; Wang Q; Li J Biomaterials; 2010 Mar; 31(7):1830-8. PubMed ID: 19942284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]